GLOBUS MEDICAL INC - 8-K Filing
Globus Medical reported Q1 2026 revenue of $759.9 million (+27% YoY), with GAAP diluted EPS at $0.90 (+66.6% YoY) and non-GAAP diluted EPS at $1.12 (+64.7%). The company reaffirmed full-year 2026 revenue guidance of $3.18–$3.22 billion and raised non-GAAP fully diluted EPS guidance to $4.70–$4.80 from a prior range of $4.40–$4.50. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $GMED